{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:49:09Z","timestamp":1787636949518,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We profiled the gene expression in the hypothalamic arcuate nuclei (ARC) of 20 male and 20 female rats to determine the infantile spasms (IS) related transcriptomic alteration of neurotransmission and recovery following two treatments. Rats were prenatally exposed to betamethasone or saline followed by repeated postnatal subjection to NMDA-triggered IS. Rats with spasms were treated with ACTH, PMX53 or saline. Since ACTH, the first line treatment for IS, has inconsistent efficacy and potential harsh side effects, PMX53, a potent complement C5ar1 antagonist, was suggested as a therapeutic alternative given its effects in other epilepsy models. Novel measures that consider all genes and are not affected by arbitrary cut-offs were used, in addition to standard statistical tests, to quantify regulation and recovery of glutamatergic, GABAergic, cholinergic, dopaminergic and serotonergic pathways. Although IS alters expression of ~30% of the ARC genes in both sexes the transcriptomic effects are 3\u00d7 more severe in males than their female counterparts, as indicated by the Weighted Pathway Regulation measure. Both treatments significantly restored the ARC neurotransmission transcriptome to the non-IS condition with PMX53 performing slightly better, as measured by the Pathway Restoration Efficiency, suggesting these treatments may reduce autistic traits often associated with IS.<\/jats:p>","DOI":"10.1038\/s41598-018-24013-x","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T14:50:40Z","timestamp":1523458240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["ACTH and PMX53 recover synaptic transcriptome alterations in a rat model of infantile spasms"],"prefix":"10.1038","volume":"8","author":[{"given":"Dumitru A.","family":"Iacoba\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Chachua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanda","family":"Iacoba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Vel\u00ed\u0161kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libor","family":"Vel\u00ed\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"key":"24013_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s13311-014-0301-2","volume":"11","author":"SE Nieh","year":"2014","unstructured":"Nieh, S. E. & Sherr, E. H. Epileptic encephalopathies: new genes and new pathways. Neurotherapeutics 11, 796\u2013806 (2014).","journal-title":"Neurotherapeutics"},{"key":"24013_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/01.wco.0000162847.91531.9c","volume":"18","author":"R Riikonen","year":"2005","unstructured":"Riikonen, R. The latest on infantile spasms. Curr Opin Neurol. 18, 91\u201395 (2005).","journal-title":"Curr Opin Neurol."},{"key":"24013_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/B978-0-444-52891-9.00063-4","volume":"111","author":"RA Hrachovy","year":"2013","unstructured":"Hrachovy, R. A. & Frost, J. D. Jr. Infantile spasms. Handb Clin Neurol. 111, 611\u2013618 (2013).","journal-title":"Handb Clin Neurol."},{"key":"24013_CR4","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1212\/WNL.0b013e318259e2cf","volume":"78","author":"CY Go","year":"2012","unstructured":"Go, C. Y. et al. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 78, 1974\u20131980 (2012).","journal-title":"Neurology"},{"key":"24013_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/BF00443098","volume":"148","author":"R Riikonen","year":"1989","unstructured":"Riikonen, R. et al. Hormonal background of the hypertension and fluid derangements associated with adrenocorticotrophic hormone treatment of infants. Eur J Pediatr 148, 737\u2013741 (1989).","journal-title":"Eur J Pediatr"},{"key":"24013_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0387-7604(01)00307-2","volume":"23","author":"R Riikonen","year":"2001","unstructured":"Riikonen, R. Long-term outcome of patients with West syndrome. Brain Dev 23, 683\u2013687 (2001).","journal-title":"Brain Dev"},{"key":"24013_CR7","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/j.1528-1167.2007.01150.x","volume":"48","author":"E Saemundsen","year":"2007","unstructured":"Saemundsen, E., Ludvigsson, P., Hilmarsdottir, I. & Rafnsson, V. Autism spectrum disorders in children with seizures in the first year of life - a population-based study. Epilepsia 48, 1724\u20131730 (2007).","journal-title":"Epilepsia"},{"key":"24013_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1017\/S003329171400172X","volume":"45","author":"AJ Baxter","year":"2015","unstructured":"Baxter, A. J. et al. The epidemiology and global burden of autism spectrum disorders. Psychol Med 45, 601\u2013613 (2015).","journal-title":"Psychol Med"},{"issue":"1","key":"24013_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","volume":"7","author":"A Vezzani","year":"2011","unstructured":"Vezzani, A., French, J., Bartfai, T. & Baram, T. Z. The role of inflammation in epilepsy. Nat Rev Neurol. 7(1), 31\u201340 (2011).","journal-title":"Nat Rev Neurol."},{"issue":"4","key":"24013_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nbd.2015.02.004","volume":"76","author":"MJ Benson","year":"2015","unstructured":"Benson, M. J. et al. A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models. Neurobiol Dis. 76(4), 87\u201397 (2015).","journal-title":"Neurobiol Dis."},{"issue":"6","key":"24013_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/epi.12960","volume":"56","author":"MJ Benson","year":"2015","unstructured":"Benson, M. J., Manzanero, S. & Borges, K. Complex alterations in microglial M1\/M2 markers during the development of epilepsy in two mouse models. Epilepsia 56(6), 895\u2013905 (2015).","journal-title":"Epilepsia"},{"issue":"1","key":"24013_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.20315","volume":"57","author":"DL Vargas","year":"2005","unstructured":"Vargas, D. L. et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 57(1), 67\u201381 (2005).","journal-title":"Ann Neurol."},{"issue":"5","key":"24013_CR13","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.molimm.2006.03.007","volume":"44","author":"DM Bonifati","year":"2007","unstructured":"Bonifati, D. M. & Kishore, U. Role of complement in neurodegeneration and neuroinflammation. Mol Immunol. 44(5), 999\u20131010 (2007).","journal-title":"Mol Immunol."},{"issue":"7","key":"24013_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","volume":"96","author":"A Vezzani","year":"2015","unstructured":"Vezzani, A. & Viviani, B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacol. 96(7), 70\u201382 (2015).","journal-title":"Neuropharmacol."},{"issue":"4","key":"24013_CR15","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1111\/epi.13698","volume":"58","author":"MJ Benson","year":"2017","unstructured":"Benson, M. J., Manzanero, S. & Borges, K. The effects of C5ar1 on leukocyte infiltration following pilocarpine-induced status epilepticus. Epilepsia 58(4), e54\u201358 (2017).","journal-title":"Epilepsia"},{"key":"24013_CR16","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1096\/fj.05-5814com","volume":"20","author":"TM Woodruff","year":"2006","unstructured":"Woodruff, T. M. et al. Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. FASEB J. 20, 1407\u20131417 (2006).","journal-title":"FASEB J."},{"key":"24013_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nature10360","volume":"477","author":"O Yizhar","year":"2011","unstructured":"Yizhar, O. et al. Neocortical excitation\/inhibition balance in information processing and social dysfunction. Nature 477, 171\u2013178 (2011).","journal-title":"Nature"},{"key":"24013_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/ana.21082","volume":"61","author":"L Vel\u00ed\u0161ek","year":"2007","unstructured":"Vel\u00ed\u0161ek, L., Jehle, K., Asche, S. & Vel\u00ed\u0161kov\u00e1, J. Model of infantile spasms induced by N-methyl-D-aspartic acid in prenatally impaired brain. Ann Neurol 61, 109\u2013119 (2007).","journal-title":"Ann Neurol"},{"key":"24013_CR19","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1111\/j.1528-1167.2011.03357.x","volume":"53","author":"MS Yum","year":"2012","unstructured":"Yum, M. S., Chachua, T., Vel\u00ed\u0161kov\u00e1, J. & Vel\u00ed\u0161ek, L. Prenatal stress promotes development of spasms in infant rats. Epilepsia 53, e46\u201349, https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03357.x (2012).","journal-title":"Epilepsia"},{"key":"24013_CR20","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/epi.13434","volume":"57","author":"T Chachua","year":"2016","unstructured":"Chachua, T. et al. Estradiol does not affect spasms in the betamethasone-NMDA rat model of infantile spasms. Epilepsia 57, 1326\u20131336 (2016).","journal-title":"Epilepsia"},{"key":"24013_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000241012","volume":"32","author":"A Gottlieb","year":"1977","unstructured":"Gottlieb, A., Keydar, I. & Epstein, H. T. Rodent brain growth stages: an analytical review. Biol Neonate 32, 166\u2013176 (1977).","journal-title":"Biol Neonate"},{"key":"24013_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0166-2236(02)02241-5","volume":"25","author":"S Avishai-Eliner","year":"2002","unstructured":"Avishai-Eliner, S., Brunson, K. L., Sandman, C. A. & Baram, T. Z. Stressed-out, or in (utero)? Trends Neurosci. 25, 518\u2013524 (2002).","journal-title":"Trends Neurosci."},{"key":"24013_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0165-3806(92)90178-Y","volume":"65","author":"P Mare\u0161","year":"1992","unstructured":"Mare\u0161, P. & Vel\u00ed\u0161ek, L. N-methyl-D-aspartate (NMDA)-induced seizures in developing rats. Brain Res Dev Brain Res. 65, 185\u2013189 (1992).","journal-title":"Brain Res Dev Brain Res."},{"key":"24013_CR24","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/j.1528-1167.2011.03220.x","volume":"52","author":"T Chachua","year":"2011","unstructured":"Chachua, T., Yum, M.-S., Vel\u00ed\u0161kov\u00e1, J. & Vel\u00ed\u0161ek, L. Validation of the rat model of cryptogenic infantile spasms. Epilepsia 52, 1666\u20131677 (2011).","journal-title":"Epilepsia"},{"key":"24013_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/epi.13315","volume":"57","author":"M Tsuji","year":"2016","unstructured":"Tsuji, M., Takahashi, Y., Watabe, A. M. & Kato, F. Enhanced long-term potentiation in mature rats in a model of epileptic spasms with betamethasone-priming and postnatal N-methyl-d-aspartate administration. Epilepsia 57, 495\u2013505 (2016).","journal-title":"Epilepsia"},{"key":"24013_CR26","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/jne.12061","volume":"25","author":"DA Iacobas","year":"2013","unstructured":"Iacobas, D. A. et al. Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: Insights from a novel animal model of infantile spasms. J Neuroendocrinol. 25, 964\u2013979 (2013).","journal-title":"J Neuroendocrinol."},{"key":"24013_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1017\/S1740925X10000220","volume":"6","author":"S Iacobas","year":"2010","unstructured":"Iacobas, S. & Iacobas, D. A. Astrocyte proximity modulates the myelination gene fabric of oligodendrocytes. Neuron Glia Biol. 6, 157\u201369 (2010).","journal-title":"Neuron Glia Biol."},{"key":"24013_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00438-012-0673-0","volume":"287","author":"S Iacobas","year":"2012","unstructured":"Iacobas, S., Thomas, N. M. & Iacobas, D. A. Plasticity of the myelination genomic fabric. Mol. Genet. Genomics 287, 237\u201346 (2012).","journal-title":"Mol. Genet. Genomics"},{"issue":"3","key":"24013_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13752-016-0245-3","volume":"11","author":"DA Iacobas","year":"2016","unstructured":"Iacobas, D. A. The genomic fabric perspective on the transcriptome between universal quantifiers and personalized genomic medicine. Biological Theory 11(3), 123\u2013137 (2016).","journal-title":"Biological Theory"},{"issue":"2","key":"24013_CR30","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.18632\/oncotarget.23417","volume":"9","author":"DA Iacobas","year":"2018","unstructured":"Iacobas, D. A. et al. Gene master regulators of papillary and anaplastic thyroid cancer phenotypes. Oncotarget 9(2), 2410\u20132424 (2018).","journal-title":"Oncotarget"},{"key":"24013_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.expneurol.2014.09.013","volume":"263","author":"MTK Zia","year":"2014","unstructured":"Zia, M. T. K. et al. Postnatal glucocorticoid-induced hypomyelination, gliosis, neurologic deficits are dose-dependent, preparation-specific, and reversible. Exp Neurol. 263, 200\u2013213 (2014).","journal-title":"Exp Neurol."},{"issue":"1","key":"24013_CR32","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/ejn.12168","volume":"38","author":"LK Friedman","year":"2013","unstructured":"Friedman, L. K. et al. Transcriptome Profiling of Hippocampal CA1 after Early Life Seizure-Induced Preconditioning May Elucidate New Genetic Therapies for Epilepsy. Eur J Neurosci. 38(1), 2139\u201352 (2013).","journal-title":"Eur J Neurosci."},{"key":"24013_CR33","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ajhg.2016.07.013","volume":"99","author":"D Li","year":"2016","unstructured":"Li, D. et al. GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers. Am J Hum Genet 99, 802\u2013816 (2016).","journal-title":"Am J Hum Genet"},{"key":"24013_CR34","doi-asserted-by":"crossref","unstructured":"Epi4K and EPGP Investigators. De novo mutations in the classic epileptic encephalopathies. Nature. 501(7466), 217\u2013221 (2013).","DOI":"10.1038\/nature12439"},{"issue":"18","key":"24013_CR35","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1093\/hmg\/ddu199","volume":"23","author":"JL Michaud","year":"2014","unstructured":"Michaud, J. L. et al. The genetic landscape of infantile spasms. Hum Mol Genet. 23(18), 4846\u20134858 (2014).","journal-title":"Hum Mol Genet."},{"issue":"1","key":"24013_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/ana.24073","volume":"75","author":"JR Lemke","year":"2014","unstructured":"Lemke, J. R. et al. GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy. Ann Neurol 75(1), 147\u2013154 (2014).","journal-title":"Ann Neurol"},{"issue":"6","key":"24013_CR37","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.410440603","volume":"44","author":"DC Chugani","year":"1998","unstructured":"Chugani, D. C. et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol. 44(6), 858\u2013866 (1998).","journal-title":"Ann Neurol."},{"key":"24013_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0074-7742(02)49005-8","volume":"49","author":"C Juhasz","year":"2002","unstructured":"Juhasz, C., Chugani, H. T., Muzik, O. & Chugani, D. C. Hypotheses from functional neuroimaging studies. Int Rev Neurobiol. 49, 37\u201355 (2002).","journal-title":"Int Rev Neurobiol."},{"issue":"7","key":"24013_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/BF00441530","volume":"148","author":"H Sugie","year":"1989","unstructured":"Sugie, H., Sugie, Y., Kato, N. & Fukuyama, Y. A patient with infantile spasms and low homovanillic acid levels in cerebrospinal fluid: L-dopa dependent seizures? Eur J Pediatr. 148(7), 667\u2013668 (1989).","journal-title":"Eur J Pediatr."},{"issue":"3","key":"24013_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0387-7604(89)80099-3","volume":"11","author":"CA Chiriboga","year":"1989","unstructured":"Chiriboga, C. A., Pranzatelli, M. R. & De Vivo, D. C. Chronic ACTH treatment increases striatal dopamine D-2 receptor binding in developing rat brain. Brain & Development 11(3), 197\u2013200 (1989).","journal-title":"Brain & Development"},{"issue":"4","key":"24013_CR41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1528-1157.1980.tb04086.x","volume":"21","author":"M Ito","year":"1980","unstructured":"Ito, M., Okuno, T., Mikawa, H. & Osumi, Y. Elevated homovanillic acid in cerebrospinal fluid of children with infantile spasms. Epilepsia 21(4), 387\u2013392 (1980).","journal-title":"Epilepsia"},{"key":"24013_CR42","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S0387-7604(12)80008-8","volume":"12","author":"I Rektor","year":"1990","unstructured":"Rektor, I., Svejdova, M. & Menini, C. Cholinergic system disturbance in the West syndrome. Brain Dev 12, 790\u2013794 (1990).","journal-title":"Brain Dev"},{"issue":"10","key":"24013_CR43","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/ajmg.a.36085","volume":"161A","author":"E Lacaze","year":"2013","unstructured":"Lacaze, E. et al. De novo 15q13.3 microdeletion with cryptogenic West syndrome. Am J Med Genet A 161A(10), 2582\u20132587 (2013).","journal-title":"Am J Med Genet A"},{"issue":"12","key":"24013_CR44","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/jne.12332","volume":"27","author":"J Vel\u00ed\u0161kov\u00e1","year":"2015","unstructured":"Vel\u00ed\u0161kov\u00e1, J. et al. Estradiol regulates neuropeptide Y release and the gene coupling with GABAergic and glutamatergic synapse in adult female rat dentate gyrus. J Neuroend. 27(12), 911\u201320 (2015).","journal-title":"J Neuroend."},{"issue":"1\u20132","key":"24013_CR45","first-page":"168","volume":"94","author":"DA Iacobas","year":"2007","unstructured":"Iacobas, D. A., Iacobas, S. & Spray, D. C. Connexin-dependent transcellular transcriptomic networks in mouse brain. Prog Biophys Mol Biol. 94(1\u20132), 168\u2013184 (2007).","journal-title":"Prog Biophys Mol Biol."},{"issue":"1","key":"24013_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ygeno.2006.09.007","volume":"89","author":"DA Iacobas","year":"2007","unstructured":"Iacobas, D. A., Iacobas, S. & Spray, D. C. Connexin43 and the brain transcriptome of the newborn mice. Genomics. 89(1), 113\u2013123 (2007).","journal-title":"Genomics."},{"key":"24013_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.seizure.2016.06.021","volume":"41","author":"E Ture","year":"2016","unstructured":"Ture, E. et al. Comparison of the serum cytokine levels before and after adrenocorticotropic hormone (ACTH) therapy in patients with infantile spasm. Seizure 41, 112\u2013115 (2016).","journal-title":"Seizure"},{"key":"24013_CR48","doi-asserted-by":"publisher","first-page":"7484","DOI":"10.1523\/JNEUROSCI.0551-10.2010","volume":"30","author":"CM Dube","year":"2010","unstructured":"Dube, C. M. et al. Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci 30, 7484\u20137494 (2010).","journal-title":"J Neurosci"},{"issue":"9","key":"24013_CR49","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1096\/fj.05-5814com","volume":"20","author":"TM Woodruff","year":"2006","unstructured":"Woodruff, T. M. et al. Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. FASEB J. 20(9), 1407\u20131417 (2006).","journal-title":"FASEB J."},{"issue":"1","key":"24013_CR50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neulet.2007.07.012","volume":"424","author":"JW Crane","year":"2007","unstructured":"Crane, J. W. & Buller, K. M. Systemic blockade of complement C5a receptors reduces lipopolysacharride-induced responses in the paraventricular nucleus and the central amygdala. Neurosci Lett. 424(1), 10\u201315 (2007).","journal-title":"Neurosci Lett."},{"issue":"17","key":"24013_CR51","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.15252\/embj.201593070","volume":"35","author":"DO Kravchick","year":"2016","unstructured":"Kravchick, D. O. et al. Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and regulates NMDA mediated excitotoxicity. EMBO J. 35(17), 1923\u201334 (2016).","journal-title":"EMBO J."},{"issue":"1","key":"24013_CR52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bbrc.2006.08.056","volume":"349","author":"DA Iacobas","year":"2006","unstructured":"Iacobas, D. A. et al. Transcriptomic changes in developing kidney exposed to chronic hypoxia. Biochem Biophys Res Comm. 349(1), 329\u2013338 (2006).","journal-title":"Biochem Biophys Res Comm."},{"key":"24013_CR53","doi-asserted-by":"publisher","unstructured":"Lee, P. R., Cohen, J. E., Iacobas, D. A., Iacobas, S. & Fields, R. D. Gene-regulatory networks activated by pattern-specific generation of action potentials in dorsal root ganglia neurons. Scientific Reports, https:\/\/doi.org\/10.1038\/srep43765 (2017).","DOI":"10.1038\/srep43765"},{"key":"24013_CR54","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353\u2013D361 (2017).","journal-title":"Nucleic Acids Res."},{"key":"24013_CR55","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"24013_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"24013_CR57","doi-asserted-by":"publisher","unstructured":"Iacobas, D. A. et al. Functional genomic fabrics are remodeled in a mouse model of Chagasic cardiomyopathy and restored following cell therapy. Microbes Infect., https:\/\/doi.org\/10.1016\/j.micinf.2017.11.003. [Epub ahead of print] (2017).","DOI":"10.1016\/j.micinf.2017.11.003."},{"issue":"9","key":"24013_CR58","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.4161\/cc.10.9.15487","volume":"10","author":"MB Soares","year":"2011","unstructured":"Soares, M. B. et al. Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells. Cell cycle 10(9), 1448\u20131455 (2011).","journal-title":"Cell cycle"},{"issue":"1","key":"24013_CR59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s12015-011-9282-2","volume":"8","author":"S Lachtermacher","year":"2011","unstructured":"Lachtermacher, S. et al. Functional and Transcriptomic Recovery of Infarcted Mouse Myocardium Treated with Bone Marrow Mononuclear Cells. Stem Cell Rev. 8(1), 251\u201361 (2011).","journal-title":"Stem Cell Rev."},{"issue":"1\u20133","key":"24013_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00232-007-9039-7","volume":"217","author":"DA Iacobas","year":"2007","unstructured":"Iacobas, D. A. et al. Gap junction and purinergic P2 receptor proteins as a functional unit: insights from transcriptomics. J Membr Biol. 217(1\u20133), 83\u201391 (2007).","journal-title":"J Membr Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24013-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T22:34:53Z","timestamp":1720218893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24013-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24013"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24013-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]},"assertion":[{"value":"17 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5722"}}